InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Vig Pamela, Directeur Scientifique. Officer active across 1 companies, notably Mirum Pharmaceuticals, Inc.. Cumulatively, 9 reports have been recorded. The latest transaction was disclosed on 10 May 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Declarations9 total
€10,394807 shares@ €12.87960.0003% mcap23.0% of flow
Common Stock
SEC:0001209191-22-028725:0·
010,000 shares0
Common Stock
SEC:0001209191-22-002433·
010,000 shares0
Common Stock
SEC:0001209191-22-002433:0·
€8,951768 shares@ €11.65530.0002% mcap51.5% of flow
Common Stock
SEC:0001209191-21-064455·
€8,951768 shares@ €11.65530.0002% mcap19.8% of flow
Common Stock
SEC:0001209191-21-064455:0·
08,125 shares0
Common Stock
SEC:0001209191-21-058609·
08,125 shares0
Common Stock
SEC:0001209191-21-058609:0·
€8,417699 shares@ €12.04190.0002% mcap48.5% of flow
Common Stock
SEC:0001209191-21-032166·
€8,417699 shares@ €12.04190.0002% mcap18.7% of flow
Common Stock
SEC:0001209191-21-032166:0·
9 of 9 declarations
About Vig Pamela
Pamela Vig is the Chief Scientific Officer and Head of Research & Development at Mirum Pharmaceuticals, Inc. She is responsible for the company's research and development strategy. Her scientific expertise is essential for innovation and the development of new products.
